1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil

Modify Date: 2024-02-27 17:47:03

1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil Structure
1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil structure
Common Name 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil
CAS Number 2095417-68-6 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil


1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

 Names

Name 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil

  Biological Activity

Description 1-[6-Phosphono-2-O-methyl-β-D-ribo-hexofuranosyl]uracil is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
Related Catalog
References

[1]. Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties